gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · ALGNHealthcareOrthopedic & Surgical Supplies

Align Technology Inc (ALGN)

$164.90+8.79%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$164.90▲ 21.54% in range
Nov 4, 2025Low $132.28 · High $197.51Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Align Technology closed at $164.90 on Nov 4, up 8.79%, 16.5% below its 52-week closing high. Volume of 1.7M shares was 1.70× its 20-day average (above normal).

Split-adjusted performance: +16.6% over one month, -5.2% over six months, +19.0% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.06B, up 4.3% from a year earlier, with a net margin of 10.3%.

Short interest was 4.1M shares at the Oct 15 settlement, down 1.3% from the prior report (5.8% of float, 4.3 days to cover).

Market cap$11.71B71.0M shares
Revenue · quarter$1.06B+4.3% YoY
Diluted EPS$1.51−12.2% YoY
P/E · TTM28.3×P/S 2.8×
Net margin10.3%Gross 71.7%
Dividend yieldNone
52-week range132.28 – 197.51−16.5% from high
Volume1.7M1.70× 20-day avg
Volatility · 60d35.3%Annualised
Short % of float5.8%4.3 days to cover
Net cash$1.10BCash $1.10B
Next earnings—Not scheduled
Split-adjusted performance
1W +7.3%1M +16.6%3M −2.5%6M −5.2%YTD +5.6%1Y +19.0%3Y −11.7%5Y −72.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Orthopedic & Surgical Supplies

Percentile among 22 companies (100 = best)

6-month momentum30
Revenue growth26
Net margin79
Value (low P/E)57
Size81

Industry medians: 6-month return +1.5%, revenue growth +12.8%, net margin −2.8%, P/E 29.2×.

Short interest

Details →
Shares short4.1M−1.3% vs prior
Days to cover4.3Settled Oct 15
% of float5.8%
Short vol. 10d61.1%of daily volume

Closest peers by size in Orthopedic & Surgical Supplies

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ALGNAlign Technology$164.90+8.79%−5.2%+4.3%10.3%28.3$11.71B
MSAMine Safety Incorporated$177.60+2.03%+2.1%+14.5%10.9%22.6$6.85BCompare
ZBHZimmer Biomet Holdings$110.15+13.49%+33.0%+4.8%9.1%26.0$21.01BCompare
STESTERIS$247.91+7.16%+15.6%+7.3%13.4%30.0$24.17BCompare
EWEdwards Lifesciences$99.37+4.39%+19.4%+13.6%13.9%57.0$57.28BCompare
ESTAEstablishment Labs Holdings$66.94+9.02%−10.2%+31.7%−17.4%—$1.99BCompare
ENOVEnovis$24.42+16.90%−1.7%+3.2%−0.2%—$1.41BCompare
CDRECadre Holdings$30.84−0.71%0.0%+31.8%5.5%36.6$1.32BCompare
ISRGIntuitive Surgical$482.10+9.38%+6.7%+21.7%17.1%57.6$170.32BCompare

News about Align Technology

All news →
ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock FallsZacks Investment Research · 6d ago▼ NegativeWill Align Technology (ALGN) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · Oct 2, 2026▲ PositiveAlign Technology Shares Jump Following Report Of Large Elliott PositionBenzinga · Mar 19, 2026▲ PositiveGlobal Shift to Clear Aligners to Build a USD 99.44 Billion Market by 2034GlobeNewswire Inc. · Feb 10, 2026▲ Positive

Quick answers

What does Align Technology do?
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling a lion's share of the market.
What is ALGN's market cap?
$11.71B, based on the Nov 4 close of $164.90.
What is ALGN's P/E ratio?
28.3× trailing-twelve-month earnings of $413.58M.
Does Align Technology pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ALGN is sold short?
4.1M shares, 5.8% of float, as of Oct 15, 2026.
What sector is ALGN in?
Healthcare, in the Orthopedic & Surgical Supplies industry.

About Align Technology

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling a lion's share of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. Invisalign treats over 2 million cases annually, or roughly 10% of all orthodontic cases and has treated over 20 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

HQ: Tempe, AZ20,435 employeesListed Jan 26, 2001aligntech.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology